Neurocrine halts development of schizophrenia drug as trial fails - Reuters

Reuters | Sept. 12, 2024, 5:04 p.m. | Original
Neurocrine halts development of schizophrenia drug as trial fails Reuters
Arizona's battle over crucial copper mine poised to sway US election - Reuters Argentina reduces energy subsidies, calls for fresh investment - Reuters